🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

BOND-003: The final analysis of Intravesical Cretostimogene Grenadenorepvec (n=112). for High-Risk BCG unresponsive NMIBC with CIS. CR=75% & 12 months DFS= 50% (of ITT population). This looks in line with other adenoviral gene therapies - INFa (adstiladein) #AUA25

Join us at the 51st Annual Meeting of Austrian & Bavarian Urologists’ — May 22–24 at Messe Wien! Expect tumor boards, fiery debates, state-of-the-art lectures, posters, hands-on courses, & dedicated nursing track. Check it out & register here: conventiongroup.at/events/51-tagu…

Save the Date! 51. Tagung der ÖGU & Bayerischen Urologenvereinigung 22.–24. Mai 2025 | Messe Wien Tumorboards, Debatten, Top-Vorträge, Hands-on-Kurse & Pflege-Track – Wien wartet auf euch! Mehr Infos & Anmeldung: conventiongroup.at/events/51-tagu…

Laser en bloc RBT is becoming widespread for its efficacy, safety and faster recovery. Join us on May 8-9📌 at MedUni Wien for a workshop organized by David D'Andrea and led by Shahrokh F. Shariat. Don’t miss lectures, debates, and live surgeries at one of the best 🌎universities.

Please join us in beautiful Vienna for a unique opportunity to learn and connect with esteemed colleagues from around the world. Seats are limited, please register soon.  • Registration: isupweb.org/isup/events/

Ever wondered what side effects come with PARP inhibitors in #prostatecancer? Our new review in Current Opinion in #Urology breaks down their toxicity profile and why close monitoring matters. Nyirády Dr. Péter Marcin Miszczyk Shahrokh F. Shariat Tibor Szarvas tinyurl.com/ym3frddm

Poised to Reshape Treatment Landscape: The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic ‌Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS prnewswire.com/news-releases/…

PSA decline = survival signal in advanced #ProstateCancer In a meta-analysis of 14 studies (n=8883), PSA response to ADT+ARPI was consistently associated with better OS across mHSPC, nmCRPC & mCRPC. A potential early (surrogate?) marker of efficacy. pubmed.ncbi.nlm.nih.gov/40379533/

Shahrokh Shariat appointed Honorary Professor at Al-Ahliyya Amman University meduniwien.ac.at/web/en/ueber-u…

kurier.at/wissen/gesundh…

🚨Exercise after #cancer diagnosis🚨 🏋️‍♀️🏋️‍♂️Ask any of my patients with cancer & you'll hear I always encourage fitness ✍️This new work in JNCI shows exercise after a new cancer diagnosis is associated with longer survival 👉This was true for patients with many GU cancers

Excited to share our latest paper on ARPI monotherapy in #ProstateCancer Eur Urol Focus EAU YAU Prostate Cancer Working Group Marcin Miszczyk Alexander Giesen Juan Gómez Rivas Axel S. Merseburger steven joniau Giancarlo Marra Nyirády Dr. Péter Giorgio Gandaglia Shahrokh F. Shariat Pawel Rajwa Semmelweis University Urologic Oncology Research MedUni Vienna tinyurl.com/48d4hdtk

Honored to give the Amer. Urol. Assn. #AUA talk at OBAY25 with special thanks to Shahrokh F. Shariat for the kind invitation. Also proud of MPallauf and Stephan Brönimann for sweeping 1st and 3rd place in the conference based on work during their time The Johns Hopkins Brady Urological Institute 💪🏽

Immensely grateful to Shahrokh F. Shariat for our growing friendship and collaboration bridging MedUni Wien Urologic Oncology Research MedUni Vienna and The Johns Hopkins Brady Urological Institute over the years. Excited to see how far we have come and what we can accomplish together in the future 💪🏽

CCC TRIO 2025 – Translational Research In Oncology 2 inspiring days of scientific excellence, collaboration & community building. 📅 June 12–13, 2025 📍 AKH Vienna Hörsaalzentrum, Level 8 🔗 Registration & Program (18 DFP) Submit your Abstract & win!

⚡️ The CHMP recommends EU approval of perioperative durvalumab for muscle-invasive bladder cancer, based on phase 3 NIAGARA trial data. 🔹 Significant improvement in event-free survival 🔹 First perioperative immunotherapy for MIBC in Europe 🔹 A potential shift in standard of

Very proud to have received top prostate cancer abstract award at the 51. Tagung der Österreichischen Gesellschaft für Urologie und Andrologie sowie der Bayerischen Urologenvereinigung! The past year under the mentorship of Shahrokh F. Shariat and with the support of European Association of Urology (EAU) has been

Together with Prof. Bhaskar Somani Prof Bhaskar Somani, we have become the editors of the latest issue of Current Opinion in Urology journals.lww.com/co-urology/pag… This issue features the most significant achievements in endourology over the past few years. Don't miss it!

CCC Lifetime Achievement Awards to Reinhard Kirnbauer & Elmar Joura - Join us at CCC TRIO 2025, June 12–13, AKH Wien. For their outstanding contributions to the development & global implementation of the HPV vaccine, saving innumerable lives worldwide. ccc.meduniwien.ac.at/forschung/ccc-…